EFFECT OF BROMOCRIPTINE AND METERGOLINE IN THE TREATMENT OF HYPERPROLACTINEMIC STATES

[1] SEROTONIN INVOLVEMENT IN INHIBITION OF EPISODIC LUTEINIZING-HORMONE RELEASE DURING ELECTRICAL-STIMULATION OF MIDBRAIN DORSAL RAPHE NUCLEUS IN OVARIECTOMIZED RATS [J]. ENDOCRINOLOGY, 1978, 102 (04) : 1199 - 1206

[2] METERGOLINE AND CYPROHEPTADINE SUPPRESS PROLACTIN-RELEASE BY A NON-5-HYDROXYTRYPTAMINERGIC, NON-DOPAMINERGIC MECHANISM [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1980, 70 (01) : 5 - 7

[3] CROSIGNANI PG, 1979, FERTIL STERIL, V32, P280

[4] PERSISTING SUPPRESSION OF PROLACTIN SECRETION AFTER LONG-TERM TREATMENT WITH BROMOCRIPTINE IN PATIENTS WITH PROLACTINOMAS [J]. ACTA ENDOCRINOLOGICA, 1979, 92 (03): : 413 - 427

[5] INHIBITORY EFFECT OF SEROTONIN ANTAGONISTS ON GROWTH-HORMONE RELEASE IN ACROMEGALIC PATIENTS [J]. CLINICAL ENDOCRINOLOGY, 1976, 5 (01) : 71 - 78

[6] FLUCKIGER E, 1976, PHARM CLIN ASPECTS B, P12

[7] EFFECTS OF METHERGOLINE ON CENTRAL MONOAMINE NEURONS - EVIDENCE FOR A SELECTIVE BLOCKADE OF CENTRAL 5-HT RECEPTORS [J]. NEUROSCIENCE LETTERS, 1975, 1 (05) : 283 - 290

[8] REGRESSION OF PITUITARY-TUMORS, A POSSIBLE EFFECT OF BROMERGOCRYPTINE [J]. AMERICAN JOURNAL OF MEDICINE, 1979, 66 (04) : 697 - 702

[9] INABILITY OF BROMOCRIPTINE TO INHIBIT PROLACTIN SECRETION BY TRANSPLANTABLE RAT PITUITARY TUMORS - OBSERVATIONS ON THE MECHANISM AND DYNAMICS OF THE AUTOFEEDBACK REGULATION OF PROLACTIN SECRETION [J]. ENDOCRINOLOGY, 1979, 104 (01) : 65 - 70

[10] LAMBERTS SWJ, 1979, P SOC EXP BIOL MED, V162, P75, DOI 10.3181/00379727-162-40621

[1] SEROTONIN INVOLVEMENT IN INHIBITION OF EPISODIC LUTEINIZING-HORMONE RELEASE DURING ELECTRICAL-STIMULATION OF MIDBRAIN DORSAL RAPHE NUCLEUS IN OVARIECTOMIZED RATS [J]. ENDOCRINOLOGY, 1978, 102 (04) : 1199 - 1206

[2] METERGOLINE AND CYPROHEPTADINE SUPPRESS PROLACTIN-RELEASE BY A NON-5-HYDROXYTRYPTAMINERGIC, NON-DOPAMINERGIC MECHANISM [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1980, 70 (01) : 5 - 7

[3] CROSIGNANI PG, 1979, FERTIL STERIL, V32, P280

[4] PERSISTING SUPPRESSION OF PROLACTIN SECRETION AFTER LONG-TERM TREATMENT WITH BROMOCRIPTINE IN PATIENTS WITH PROLACTINOMAS [J]. ACTA ENDOCRINOLOGICA, 1979, 92 (03): : 413 - 427

[5] INHIBITORY EFFECT OF SEROTONIN ANTAGONISTS ON GROWTH-HORMONE RELEASE IN ACROMEGALIC PATIENTS [J]. CLINICAL ENDOCRINOLOGY, 1976, 5 (01) : 71 - 78

[6] FLUCKIGER E, 1976, PHARM CLIN ASPECTS B, P12

[7] EFFECTS OF METHERGOLINE ON CENTRAL MONOAMINE NEURONS - EVIDENCE FOR A SELECTIVE BLOCKADE OF CENTRAL 5-HT RECEPTORS [J]. NEUROSCIENCE LETTERS, 1975, 1 (05) : 283 - 290

[8] REGRESSION OF PITUITARY-TUMORS, A POSSIBLE EFFECT OF BROMERGOCRYPTINE [J]. AMERICAN JOURNAL OF MEDICINE, 1979, 66 (04) : 697 - 702

[9] INABILITY OF BROMOCRIPTINE TO INHIBIT PROLACTIN SECRETION BY TRANSPLANTABLE RAT PITUITARY TUMORS - OBSERVATIONS ON THE MECHANISM AND DYNAMICS OF THE AUTOFEEDBACK REGULATION OF PROLACTIN SECRETION [J]. ENDOCRINOLOGY, 1979, 104 (01) : 65 - 70

[10] LAMBERTS SWJ, 1979, P SOC EXP BIOL MED, V162, P75, DOI 10.3181/00379727-162-40621